Home › NCT03897374
Strategic Targeting for Optimal Prevention of Cancer
RecruitingObservational study
Who can join
Ages 65 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Study subjects may be included in the Clinical Trial if they meet all of the following inclusion criteria: * individuals, ages 65 years or older; * must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity; * hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations. * study subject has or had cancer * study subject has at least one family member with cirrent or past cancer Exclusion Criteria: * Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated; * study subject is unable to provide an accurate history due to mental incapacity * study subject is currently abusing illicit and/or prescription drugs;
About the study
The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
What is being tested
- Genetic Testing (diagnostic test)
Sponsor: ClinLogic LLC · Participants: 120,000 · Started: Mar 26, 2025
Contact the study team
- C David, MBA · Phone: 7174671201
Official record on ClinicalTrials.gov — NCT03897374
Locations in the U.S.
| Texas | Sunbeam Clinical, Prosper |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.